Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Mar-23 4:17 PM View:  | Koziel Margaret Chief Medical Officer | Axcella Health Inc. (AXLA) | 01-Mar-23 | Sale (Planned) | 679 | $0.58 | $393.82 | (3%) 25.56K to 24.88K | |
| 13-Feb-23 4:15 PM View: | Fehlner Paul SVP & Chief Legal Officer | Axcella Health Inc. (AXLA) | 10-Feb-23 | Private Sale (Planned) | 5,221 | $0.66 | $3,446.90 | 10% 52.86K to 58.08K | |
| 19-Oct-22 6:49 PM View: | Hinshaw William President & CEO Director | Axcella Health Inc. (AXLA) | 19-Oct-22 | Sale | 16,000 | $1.56 | $25,027.20 | (16%) 98.01K to 82.01K | |
| 19-Oct-22 6:49 PM View: | Hinshaw William President & CEO Director | Axcella Health Inc. (AXLA) | 17-Oct-22 | Grant | 50,000 | -- | -- | 104% 48.01K to 98.01K | |
| 17-Oct-22 11:12 AM View: | Societe Des Produits Nestle... 10% Owner | Axcella Health Inc. (AXLA) | 13-Oct-22 | Private Purchase | 3,658,540 | $1.64 | $6,000,000.00 | 49% 7.45M to 11.11M | |
| 17-Oct-22 4:42 PM View: | Flagship Ventures Fund Iv G... 10% Owner | Axcella Health Inc. (AXLA) | 13-Oct-22 | Private Purchase | 10,383,800 | $1.64 | $17,029,400.00 | 55% 18.87M to 29.25M | |
| 08-Sep-22 5:52 PM View: | Koziel Margaret Chief Medical Officer | Axcella Health Inc. (AXLA) | 06-Sep-22 | Private Sale | 547 | $2.52 | $1,378.17 | (2%) 26.11K to 25.56K | |
| 02-Jun-22 5:04 PM View: | Koziel Margaret Chief Medical Officer | Axcella Health Inc. (AXLA) | 01-Jun-22 | Market Sale | 590 | $2.01 | $1,186.31 | (2%) 26.7K to 26.11K | 2% |
| 03-Jun-22 4:30 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 19-May-22 | Grant | 47,059 | -- | -- | 29% 162.7K to 209.76K | |
| 21-Mar-22 4:30 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 18-Mar-22 | Option Exercise | 1,535 | -- | -- | < 1% 161.16K to 162.7K | |
| 18-Mar-22 8:31 AM View: | Fehlner Paul SVP & Chief Legal Officer | Axcella Health Inc. (AXLA) | 16-Mar-22 | Market Purchase | 10,471 | $1.91 | $19,999.60 | 101% 10.33K to 20.8K | 3% |
| 18-Mar-22 8:31 AM View: | Hinshaw William President & CEO Director | Axcella Health Inc. (AXLA) | 16-Mar-22 | Market Purchase | 13,089 | $1.91 | $25,000.00 | 37% 34.92K to 48.01K | 3% |
| 18-Mar-22 8:30 AM View: | Flagship Ventures Fund Iv G... 10% Owner | Axcella Health Inc. (AXLA) | 16-Mar-22 | Market Purchase | 6,319,370 | $1.91 | $12,070,000.00 | 50% 12.55M to 18.87M | 3% |
| 18-Mar-22 8:30 AM View: | Crane Robert Chief Financial Officer | Axcella Health Inc. (AXLA) | 16-Mar-22 | Market Purchase | 39,267 | $1.91 | $75,000.00 | 100% 0 to 39.27K | 3% |
| 18-Mar-22 8:30 AM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 16-Mar-22 | Market Purchase | 26,178 | $1.91 | $50,000.00 | 19% 134.98K to 161.16K | 3% |
| 16-Mar-22 11:53 AM View: | Societe Des Produits Nestle... 10% Owner | Axcella Health Inc. (AXLA) | 16-Mar-22 | Market Purchase | 3,141,360 | $1.91 | $6,000,000.00 | 73% 4.31M to 7.45M | 3% |
| 03-Mar-22 4:19 PM View: | Koziel Margaret Chief Medical Officer | Axcella Health Inc. (AXLA) | 01-Mar-22 | Market Sale | 553 | $1.86 | $1,029.58 | (2%) 27.25K to 26.7K | (6%) |
| 23-Feb-22 4:19 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 18-Feb-22 | Option Exercise | 1,534 | -- | -- | 1% 133.45K to 134.98K | |
| 01-Feb-22 4:30 PM View: | Hinshaw William President and CEO Director | Axcella Health Inc. (AXLA) | 31-Jan-22 | Option Sale | 16,590 | $1.65 | $27,393.40 | (33%) 50.0K to 33.41K | |
| 01-Feb-22 4:30 PM View: | Hinshaw William President and CEO Director | Axcella Health Inc. (AXLA) | 28-Jan-22 | Option Exercise | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 20-Jan-22 4:30 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 18-Jan-22 | Option Exercise | 1,535 | -- | -- | 1% 131.91K to 133.45K | |
| 20-Dec-21 4:15 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 17-Dec-21 | Option Exercise | 1,535 | -- | -- | 1% 130.38K to 131.91K | |
| 22-Nov-21 6:04 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 18-Nov-21 | Option Exercise | 1,534 | -- | -- | 1% 128.85K to 130.38K | |
| 19-Oct-21 4:31 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 18-Oct-21 | Option Exercise | 1,535 | -- | -- | 1% 127.31K to 128.85K | |
| 20-Sep-21 4:31 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 17-Sep-21 | Option Exercise | 1,535 | -- | -- | 1% 125.78K to 127.31K | |
| 25-Aug-21 4:32 PM View: | Pisano Gary P. Director | Axcella Health Inc. (AXLA) | 13-Aug-21 | Option Exercise | 81,433 | $0.28 | $22,801.20 | 100% 0 to 81.43K | |
| 20-Jul-21 4:31 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 16-Jul-21 | Option Exercise | 1,535 | -- | -- | 1% 122.71K to 124.24K | |
| 21-Jun-21 5:42 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 18-Jun-21 | Option Exercise | 1,535 | -- | -- | 1% 121.17K to 122.71K | |
| 20-May-21 4:31 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 18-May-21 | Option Exercise | 1,534 | -- | -- | 1% 119.64K to 121.17K | |
| 20-Apr-21 4:58 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 18-Apr-21 | Option Exercise | 1,535 | -- | -- | 1% 118.1K to 119.64K | |
| 03-Feb-21 8:22 PM View: | Chakravarthy Manu SVP & Chief Medical Officer | Axcella Health Inc. (AXLA) | 01-Feb-21 | Market Option Sale | 18,472 | $5.50 | $101,631.00 | (31%) 60.0K to 41.53K | |
| 03-Feb-21 8:22 PM View: | Chakravarthy Manu SVP & Chief Medical Officer | Axcella Health Inc. (AXLA) | 01-Feb-21 | Option Exercise | 60,000 | -- | -- | 100% 0 to 60.0K | |
| 11-Feb-21 9:28 PM View: | Chardonnet Laurent Chief Financial Officer | Axcella Health Inc. (AXLA) | 30-Oct-20 | Grant | 2,601 | $3.60 | $9,363.60 | 71% 3.67K to 6.27K | |
| 09-Sep-20 8:01 PM View: | Societe Des Produits Nestle... 10% Owner | Axcella Health Inc. (AXLA) | 08-Sep-20 | Acquisition (other) | 4,305,540 | $4.42 | $19,030,500.00 | 100% 0 to 4.31M | |
| 20-May-20 5:15 PM View: | Flagship Ventures Fund Iv G... 10% Owner | Axcella Health Inc. (AXLA) | 18-May-20 | Purchase | 3,800,000 | $4.75 | $18,050,000.00 | 43% 8.75M to 12.55M | |
| 20-May-20 4:07 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 18-May-20 | Purchase | 50,000 | $4.75 | $237,500.00 | 73% 68.1K to 118.1K | |
| 21-May-20 5:02 PM View: | Nestle Health Science Us Ho... 10% Owner | Axcella Health Inc. (AXLA) | 18-May-20 | Purchase | 1,936,840 | $4.75 | $9,200,000.00 | 82% 2.37M to 4.31M | |
| 02-Mar-20 7:04 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 28-Feb-20 | Market Purchase | 2,005 | $3.75 | $7,518.75 | 3% 66.1K to 68.1K | |
| 02-Mar-20 7:04 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 27-Feb-20 | Market Purchase | 12,800 | $3.65 | $46,720.00 | 24% 53.3K to 66.1K | |
| 31-Jan-20 8:44 PM View: | Chardonnet Laurent Chief Financial Officer | Axcella Health Inc. (AXLA) | 31-Jan-20 | Market Purchase | 3,000 | $4.94 | $14,820.00 | 451% 0.67K to 3.67K | |
| 28-Jan-20 6:39 PM View: | Chardonnet Laurent Chief Financial Officer | Axcella Health Inc. (AXLA) | 27-Jan-20 | Market Purchase | 352 | $4.94 | $1,738.88 | 112% 0.31K to 0.67K | |
| 28-Jan-20 6:39 PM View: | Chardonnet Laurent Chief Financial Officer | Axcella Health Inc. (AXLA) | 24-Jan-20 | Market Purchase | 313 | $4.92 | $1,539.96 | 100% 0 to 0.31K | |
| 21-Jan-20 4:38 PM View: | Sohn Catherine A. Director | Axcella Health Inc. (AXLA) | 17-Jan-20 | Market Purchase | 1,000 | $4.87 | $4,870.00 | 100% 0 to 1.0K | |
| 03-Dec-19 11:20 AM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 27-Nov-19 | Market Purchase Duplicate | 1,005 | $3.91 | $3,929.55 | 2% 52.29K to 53.3K | |
| 02-Dec-19 7:31 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 27-Nov-19 | Market Purchase | 1,005 | $3.91 | $3,929.55 | 2% 52.29K to 53.3K | |
| 03-Dec-19 11:20 AM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 26-Nov-19 | Market Purchase Duplicate | 14,000 | $3.55 | $49,700.00 | 37% 38.29K to 52.29K | |
| 02-Dec-19 7:31 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 26-Nov-19 | Market Purchase | 14,000 | $3.55 | $49,700.00 | 37% 38.29K to 52.29K | |
| 05-Aug-19 4:55 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 02-Aug-19 | Market Purchase | 2,849 | $7.04 | $20,057.00 | 8% 35.44K to 38.29K | |
| 05-Aug-19 4:55 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 01-Aug-19 | Market Purchase | 4,092 | $6.98 | $28,562.20 | 13% 31.35K to 35.44K | |
| 18-Jul-19 9:54 PM View: | Epstein David R Director | Axcella Health Inc. (AXLA) | 17-Jul-19 | Market Purchase | 1,000 | $7.55 | $7,550.00 | 3% 30.35K to 31.35K |
